Catalyst Funds Management Pty LTD Biomarin Pharmaceutical Inc Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 400 shares of BMRN stock, worth $26,239. This represents 0.01% of its overall portfolio holdings.
Number of Shares
400Holding current value
$26,239% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
629Shares Held
178MCall Options Held
1.98MPut Options Held
1.17M-
Black Rock Inc. New York, NY22.7MShares$1.49 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.26 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.24 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$912 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$688 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...